Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Chris Lange | May 28, 2019 at 8:35 AM EDT

Major Biotechs See a Rising Tide in Short Interest

The May 15 short interest data have been compared with the previous report, and short interest in most of these…

Jon C. Ogg | May 23, 2019 at 11:40 AM EDT

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and…

Jon C. Ogg | May 23, 2019 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

The top analyst upgrades, downgrades and initiations seen on Thursday included AK Steel, Amgen, Booking, Chubb, Chipotle Mexican Grill, Expedia,…

Chris Lange | May 21, 2019 at 9:05 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors…

Jon C. Ogg | May 16, 2019 at 7:30 AM EDT

13 Dirt Cheap Dividend Stocks Valued Under 10 Times Earnings

Here are 13 dirt cheap value stocks that are valued at less than 10 times earnings and that also pay…

Chris Lange | May 10, 2019 at 8:55 AM EDT

Short Sellers Back Off Major Biotechs

The April 30 short interest data have been compared with the previous report, and short interest in most of these…

Lee Jackson | May 6, 2019 at 7:05 AM EDT

Jefferies Top Stocks to Buy Include 2 Red-Hot Marijuana Companies

These five top stocks to Buy have solid upside potential, and some of them appear to have put some past…

Jon C. Ogg | May 2, 2019 at 4:53 PM EDT

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

It’s no simple task for a biotech giant to try to sell itself to investors as a value stock. That…

Chris Lange | Apr 26, 2019 at 9:40 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The April 15 short interest data have been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Apr 24, 2019 at 12:55 PM EDT

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top…

Lee Jackson | Apr 23, 2019 at 7:40 AM EDT

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Jefferies did a deep dive into the health care sector, looking for underperforming stocks that could hold some solid value…

Chris Lange | Apr 10, 2019 at 9:15 AM EDT

Big Biotechs Confound Short Sellers

The March 29 short interest data have been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Apr 10, 2019 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Disney, Gilead, Nordstrom, Novartis, Tesla, Under Armour, Wendy’s and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Gilead Sciences, Nordstrom, Novartis, Tesla, Under Armour, Walt…

Chris Lange | Mar 27, 2019 at 8:30 AM EDT

Big Biotechs Scare Off Short Sellers

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 12, 2019 at 9:05 AM EDT

Major Biotechs See a Rising Tide in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest in most of the…

1 … 12 13 14 15 16 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Major Biotechs See a Rising Tide in Short Interest

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

13 Dirt Cheap Dividend Stocks Valued Under 10 Times Earnings

Short Sellers Back Off Major Biotechs

Jefferies Top Stocks to Buy Include 2 Red-Hot Marijuana Companies

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Big Biotechs Confound Short Sellers

Top Analyst Upgrades and Downgrades: Apple, Disney, Gilead, Nordstrom, Novartis, Tesla, Under Armour, Wendy’s and More

Big Biotechs Scare Off Short Sellers

Major Biotechs See a Rising Tide in Short Interest

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Gilead Sciences : GILD

All Gilead Sciences Articles

Major Biotechs See a Rising Tide in Short Interest

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

13 Dirt Cheap Dividend Stocks Valued Under 10 Times Earnings

Short Sellers Back Off Major Biotechs

Jefferies Top Stocks to Buy Include 2 Red-Hot Marijuana Companies

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Big Biotechs Confound Short Sellers

Top Analyst Upgrades and Downgrades: Apple, Disney, Gilead, Nordstrom, Novartis, Tesla, Under Armour, Wendy’s and More

Big Biotechs Scare Off Short Sellers

Major Biotechs See a Rising Tide in Short Interest

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings